NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GxPi’s x-docs™ CAPA Module Selected by Renovo to Manage Documents During Drug Development Process - Regulatory compliance service and product provider GxPi announced today that its x-docs™ CAPA Module has been selected by Renovo as a hosted system to manage vital documents for the company’s drug development process
GxPi’s x-docs™ CAPA Module Selected by Renovo to Manage Documents During Drug Development Process

 

NewswireTODAY - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2010/10/22 - Regulatory compliance service and product provider GxPi announced today that its x-docs™ CAPA Module has been selected by Renovo as a hosted system to manage vital documents for the company’s drug development process.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Regulatory compliance service and product provider GxPi announced today that its x-docs™ CAPA Module has been selected by Renovo as a hosted system to manage vital documents for the company’s drug development process. Renovo uses the GxPi Corrective Action and Preventive Action (CAPA) Module, which is part of the x-docs™ portfolio, to electronically track and manage its Corrective and Preventative management programme. Used in a hosted system environment, the CAPA Module minimises installation costs thereby reducing the overall implementation and licensing costs of the product for the customer. For more information on GxPi’s work with Renovo and to download the case study please visit gxpi.com.

Renovo, a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration, uses a predominantly paper-based documentation system where documents are circulated for approval and stored in a central repository. Current regulations require that a robust CAPA process is in place and that pharmaceutical organisations can demonstrate that a thorough assessment of corrective and preventative actions has been made within a given timeframe. To achieve regulatory compliance, Renovo decided to integrate an electronic system with its existing processes, selecting the GxPi CAPA Module for use as a hosted system from the GxPi data centre, due to its flexibility and ease of configuration.

Using the CAPA Module as a hosted system has removed the need for Renovo to carry out extensive installation qualification, leaving more time to focus on performance qualification testing of the system against pre-defined user requirements, as well as significantly reducing implementation and maintenance costs. The system also enables greater visibility of CAPAs across all departments without comprising the safety of data, as it is accessed remotely by authorised users via a secure internet connection to GxPi’s validated servers.

x-docs is a modular platform built on Microsoft SharePoint and facilitates simple compliance with industry regulations. The CAPA Module is based on the principle of ‘continuous improvement’, minimising delays to product and document release and sign off by enabling the efficient handling of workflow issues. As all information on any given CAPA is contained within one document, information can be handled efficiently with minimal risk of error. Being a validated electronic system, the CAPA Module also provides the assurance that approved CAPAs cannot be altered once data are submitted.

Keith Williams, CEO, GxPi, comments: “We are extremely proud to have been selected by such a prestigious organisation, leading the way in biopharmaceutical innovations. The whole integration process has been smooth and the fact that Renovo is using the module as a hosted system has reduced their overall implementation costs.”

Steve Lomax, VP Quality Assurance, Renovo commented: “We have been really impressed with the way the CAPA Module has integrated with our existing processes. Within the system, we can manage, track and resolve quality issues effectively. This helps us to maintain regulatory compliance and also raises awareness across departments of their requirements to comply with regulatory standards of GMP and GCP activities in the clinical development of pharmaceutical products.”

For more information on GxPi, please call +44 (0) 115 924 8477 or email info[.]gxpi.com. Alternatively please visit the website for further information.

About GxPi
GxPi (gxpi.com) provides consultancy services and compliance-based products to the biotechnology, pharmaceutical, consumer healthcare, medical devices and veterinary industries, enabling the development and management of compliant content. The company’s consultancy arm includes high quality, results-focused regulatory compliance (GMP, GAMP, GLP, GEP, GCP, GxP), qualified person (QP), quality assurance (QA), project management, validation, process engineering, computer systems, laboratory equipment, project management, design studies, training and clinical technology consulting services. GxPi also offers Enterprise Content Management (ECM) solutions to the life sciences sector. This provides a new class of document management software which is powerful and practical in enabling sponsors and Contract Research Organisations to comply with increasing regulatory requirements. The solutions are easy to configure, require little IT support, are cost-effective for organisations of all sizes and are entirely intuitive to use with minimal training.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GxPi’s x-docs™ CAPA Module Selected by Renovo to Manage Documents During Drug Development Process

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Scottpr.com 
+44(0)14 7753 9539 pr[.]scottpr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology
Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)